IRIS
CAPRANZANO, PIERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.380
EU - Europa 2.325
AS - Asia 911
AF - Africa 347
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 1
Totale 7.969
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.150
IE - Irlanda 877
CN - Cina 719
UA - Ucraina 593
CI - Costa d'Avorio 299
IT - Italia 288
CA - Canada 229
RU - Federazione Russa 193
VN - Vietnam 135
SE - Svezia 120
FR - Francia 65
DE - Germania 51
SN - Senegal 43
GB - Regno Unito 38
BE - Belgio 19
IN - India 19
CH - Svizzera 18
UZ - Uzbekistan 17
AT - Austria 16
NL - Olanda 15
GR - Grecia 13
SG - Singapore 11
PL - Polonia 7
EU - Europa 5
HK - Hong Kong 4
NG - Nigeria 4
FI - Finlandia 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
LB - Libano 2
BR - Brasile 1
BZ - Belize 1
ES - Italia 1
IM - Isola di Man 1
IR - Iran 1
KE - Kenya 1
KR - Corea 1
MT - Malta 1
NO - Norvegia 1
PT - Portogallo 1
TH - Thailandia 1
TR - Turchia 1
Totale 7.969
Salva come PNG Salva come JPEG
Città #
Dublin 877
Jacksonville 818
Chandler 710
Houston 496
Abidjan 299
Nanjing 249
Andover 218
Lawrence 217
Cambridge 216
Ashburn 183
Toronto 171
Des Moines 144
Boardman 137
Dong Ket 127
Catania 123
Wilmington 84
Nanchang 83
San Mateo 77
Hebei 65
Shenyang 53
Ottawa 49
Jiaxing 47
Saint Petersburg 45
Dakar 43
Tianjin 40
Changsha 39
Beijing 38
Bremen 33
Washington 29
Moscow 23
Norwalk 20
Seattle 20
Brussels 19
Pune 18
Kunming 17
Ningbo 17
Falls Church 16
Hangzhou 15
Los Angeles 15
Den Haag 11
Jinan 11
Ann Arbor 9
Liberty Lake 9
Milan 9
Guangzhou 8
Hanoi 8
Edinburgh 7
Zhengzhou 7
Canicattini Bagni 5
Manduria 5
Palermo 5
Taizhou 5
Abuja 4
Assago 4
Casarano 4
Ludwigshafen 4
Mascalucia 4
Nanaimo 4
Acireale 3
Catanzaro 3
Changchun 3
Frankfurt Am Main 3
Hong Kong 3
Licata 3
Padova 3
Phoenix 3
Pozzo Di Gotto 3
Shanghai 3
Stockholm 3
Amsterdam 2
Cagliari 2
Civitavecchia 2
Fremont 2
Groningen 2
Kiev 2
Kilburn 2
Lanzhou 2
Lappeenranta 2
Maletto 2
Messina 2
Modena 2
Pavia 2
Potenza 2
Providence 2
San Jose 2
Singapore 2
Tappahannock 2
Taranto 2
Trento 2
Venice 2
Acton 1
Ardabil 1
Atlanta 1
Augusta 1
Bangkok 1
Bedale 1
Belmopan 1
Benevento 1
Bergamo 1
Boydton 1
Totale 6.098
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 492
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 97
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 88
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry 81
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 58
Pre-dilation, Sizing and Post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffolds implantation for prediction of cardiac adverse events: development and internal validation of the PSP score 56
Clinical implication of different plaque distribution patterns in distal left main coronary artery 55
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 55
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 54
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 52
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey 51
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 51
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 51
Transfemoral transcatheter aortic-valve replacement should be preferred over surgery in most intermediate-risk patients. 51
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 50
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 50
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 50
Retrograde Approach for Chronic Total Occlusion Percutaneous Coronary Intervention: The Paradox of Choice 49
Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry 49
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 49
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 49
Appraisal of key trials in aortic and mitral fields 48
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 48
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 47
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 47
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 47
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 47
Update on clinical evidence (Part II): a summary of the main post market studies 47
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 47
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 47
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 46
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 46
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 46
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 46
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 46
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 46
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 46
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 45
Transcatheter Aortic-Valve Replacement 45
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy 45
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 45
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 45
L'angioplastica complessa al posto del by-pass: ruolo degli score di rischio 44
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 44
Percutaneous Coronary Intervention With Everolimus-Eluting Bioresorbable Vascular Scaffolds In Routine Clinical Practice: Early and Mid-Term Outcomes From The European Multicenter GHOST-EU Registry 43
Risk stratification after ST-elevation myocardial infarction 43
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 43
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease 43
Serum cotinine levels are associated with increased clopidogrel-induced antiplatelet effects 42
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 42
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 42
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 42
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 42
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 42
Early cardiovascular remodelling in Fabry disease 42
Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial 41
Percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation in patients with surgical mitral valve repair failure. 41
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 41
Capitolo 2 - Diagnostica cardiovascolare 41
Authors' Reply 41
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry) 41
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 41
Early and Midterm Outcomes of Bioresorbable Scaffolds for Ostial Coronary Lesions: Insights from the GHOST-EU Registry 41
Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation 41
Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry 41
CABG Versus PCI In Diabetic Patients With Multivessel Disease After Risk Stratification By The SYNTAX Score: A Pooled Analysis Of The SYNTAX And FREEDOM Trials 41
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 41
Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry 40
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 40
Self-apposing STENTYS stent in acute myocardial infarction 40
Impact of Chronic Kidney Disease on Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Insights From the GRASP Registry 39
PHARMACODYNAMIC EFFECTS OF DIFFERENT ASPIRIN DOSING REGIMENS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE 39
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 39
Clinical development of selective anticoagulants: a state of the art 38
One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy? 38
Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry 38
Drug-Eluting Stent for Left Main Coronary Artery Disease: The DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment 38
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonist. A review on its mechanism of action and clinical development 38
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 38
null 37
Real world safety and efficacy of the janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting Stent (TEST) registry 37
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 37
How true delivery profile diminution reduces vascular access challenges and complications 37
Increasing CHADS2 scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleeding 37
Long-term outcomes after drug-eluting stent for the treatment of ostial left anterior descending coronary artery lesions 36
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy 36
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. 36
Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients 36
SES vs PES in patients with long lesions undergoing PCI: results from a 24 months follow up 36
Impact of Adjunctive Cilostazol Therapy Versus High Maintenance Dose of Clopidogrel in Suboptimal Responders With Diabetes Mellitus 36
Is isolated disease of the ostium left anterior descending or circumflex artery a distal left main pathology? 36
Procedural management of patients with advanced heart failure undergoing MitraClip implantation (from the GRASP registry) 35
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 35
Infarto STEMI sottoposto a riperfusione con angioplastica primaria 34
Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists 34
Parenteral Anticoagulant Agents in PCI 34
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 34
The impact of diabetes mellitus on clinical long-term follow-up on the basis of clinical presentation of coronary artery disease 34
Impact of moderate preoperative chronic kidney disease on mortality after transcatheter aortic valve implantation 34
Correlation between the VerifyNow P2Y12 Assay and ligh transmission aggregometry to measure platelet P2Y12 receptor inhibition in patients on clopidogrel therapy 33
Totale 4.865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.802
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019100 0 0 0 0 0 0 0 0 0 0 32 68
2019/20201.576 529 122 143 104 170 40 181 0 76 47 107 57
2020/20211.204 6 75 169 5 312 27 169 4 91 2 184 160
2021/20221.504 172 235 2 24 261 15 227 56 117 1 21 373
2022/20232.502 223 53 20 202 343 449 9 391 693 11 75 33
2023/2024891 65 223 63 90 51 275 33 57 3 29 2 0
Totale 8.365